|
|
Volumn 309, Issue 12, 2013, Pages 1293-1294
|
|
Concerns about reliability in the Trial to Assess Chelation Therapy (TACT)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASCORBIC ACID;
ESSENTIAL OIL;
CHELATING AGENT;
EDETIC ACID;
ACCESS TO INFORMATION;
ALTERNATIVE MEDICINE;
BREAST DEVELOPMENT;
CHELATION THERAPY;
CINNAMON;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG MEGADOSE;
EDITORIAL;
EVIDENCE BASED MEDICINE;
HEALTH CARE ORGANIZATION;
HOMEOPATHY;
HUMAN;
INFLUENZA;
MALIGNANT NEOPLASTIC DISEASE;
MASTECTOMY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
QUALITY CONTROL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RELIABILITY;
RISK BENEFIT ANALYSIS;
SAMPLE SIZE;
STEM CELL TRANSPLANTATION;
STUDY DESIGN;
VALIDITY;
VULNERABLE POPULATION;
ANGINA PECTORIS;
CEREBROVASCULAR ACCIDENT;
FEMALE;
HEART INFARCTION;
MALE;
NOTE;
ANGINA PECTORIS;
CHELATING AGENTS;
EDETIC ACID;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
STROKE;
|
|
EID: 84875530533
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.2778 Document Type: Editorial |
|
Times cited : (28)
|
|
References (5)
|
